Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice.
Essy MozaffariAastha ChandakRobert L GottliebChidinma Chima-MeltonStephanie H ReadHeng JiangMel ChiangEunYoung LeeRikisha GuptaMark BerryAndre C KalilPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Prompt initiation of remdesivir in immunocompromised patients hospitalized for COVID-19 is associated with significant survival benefit across all variant waves. These findings provide much-needed evidence relating to the effectiveness of a foundational treatment for hospitalized COVID-19 patients among a high-risk population.
Keyphrases